Zhang et al. performed an online database analysis and demonstrated that RUNX1 is an independent prognostic factor in low-grade gliomas, and that it may target interferon-γ receptor 2 (IFNGR2) to regulate the proliferation, invasion, and migration of glioma cells. This evidence concerns the gene IFNGR2 and glioma.